Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Appraisal

2020 ◽  
Vol 38 (12) ◽  
pp. 1309-1318
Author(s):  
Caroline Farmer ◽  
Ash Bullement ◽  
David Packman ◽  
Linda Long ◽  
Sophie Robinson ◽  
...  
Keyword(s):  
Gene Mutations ◽  
Evidence Review Group ◽  
Technology Appraisal ◽  
Review Group ◽  
Inherited Retinal Dystrophies ◽  
Retinal Dystrophies ◽  
Evidence Review

scholarly journals Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective

2015 ◽  
Vol 33 (11) ◽  
pp. 1187-1194 ◽  
Author(s):  
Emma L. Simpson ◽  
Sarah Davis ◽  
Praveen Thokala ◽  
Penny R. Breeze ◽  
Peter Bryden ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Evidence Review Group ◽  
Technology Appraisal ◽  
Single Technology Appraisal ◽  
Review Group ◽  
Evidence Review

scholarly journals Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

2018 ◽  
Vol 36 (8) ◽  
pp. 917-927 ◽  
Author(s):  
Bram L. T. Ramaekers ◽  
Robert F. Wolff ◽  
Xavier Pouwels ◽  
Marije Oosterhoff ◽  
Anoukh Van Giessen ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Evidence Review Group ◽  
Technology Appraisal ◽  
Single Technology Appraisal ◽  
Review Group ◽  
Severe Plaque Psoriasis ◽  
Evidence Review

scholarly journals Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

2018 ◽  
Vol 36 (8) ◽  
pp. 903-915 ◽  
Author(s):  
Abdullah Pandor ◽  
Matt Stevenson ◽  
John Stevens ◽  
Marrissa Martyn-St James ◽  
Jean Hamilton ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Evidence Review Group ◽  
Technology Appraisal ◽  
Single Technology Appraisal ◽  
Review Group ◽  
Evidence Review
Sign in / Sign up

Export Citation Format

Share Document